ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

2.9%

1.6%

7.4%

8.3%

7.3%

3.5%

21.9%

10y

21.7%

all

14.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 8,172 2.9%

8,024

9,219

Company Overview

Sales

2,177 Cr

Growth: 29.5%

Profit after Tax

199 Cr

Growth: 0.1%

Mid Cap

20,429 Cr

P/E: 101.0x

Industry P/E: 26.4x

Fundamentals

Sales (Cr)	₹ 2,177
Growth	29.5%
EBITDA	13.2%
P/S	9.3x
Dividend	0.3%
P/E	101.0x
Book Value	₹ 365
PEG Ratio	3.6x
ROE	23.5%
P/B	23.1x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

AstraZeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. The company engages in execution of clinical studies to generate high quality data eligible for submissions to regulatory agencies across the world aimed at developing life altering medical products.

Belongs to (29 Indices) view more

Investors (43)

astra.ph...

all.body...

mansfiel...

Followers (3)

nitin2

keerthi

deepak